Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…–45.4]; aHR 0.25 [95% CI 0.13–0.51]; p<0.001), particularly for hepatocellular carcinoma (aHR 0.13 [95% CI 0.05–0.36]). PWH with non–virus-related NADCs…
…ne kinase (BTK) inhibitor therapy-induced RRD in a patient with breast cancer and chronic lymphocytic leukaemia. This case highlights a poten…
…nancies. Data on CAR-T use in people living with HIV (PLWH) and non-Hodgkin lymphoma (NHL) remain limited, as these patients were historically exclu…
…ssible breast cancer symptoms in primary care may help diagnose breast cancer earlier.On top of an increased likelihood of being diagnosed wi…
…Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-H…
…-cell lymphoma was diagnosed, at 50 years old, and treated by a NHL R-CHOP regimen. Also, he had psoriatic relapses and kept losing…
… study enrolled adults with relapsed/refractory solid tumors or non-Hodgkin lymphoma (NHL). Eligible patients had an Eastern Cooperative Oncology Gr…
… B-cell lymphomas including 21 Diffuse Large B-Cell Lymphoma, 5 Burkitt’s Lymphoma, 5 Central Nervous System Lymphoma, 4 Mantle Cell Lymphoma. The…
…Background Diffuse Large B-Cell Lymphoma (DLBCL), the most common non-Hodgkin lymphoma (>18,000 US cases…
…n patients with relapsed or refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia, as recently reported in NEJM.1 These cohorts employed a 3-day …
…favorable safety profile and promising efficacy across multiple non-Hodgkin lymphoma (NHL) subtypes. At the highest NKX019 dose levels, 80% of NHL p…
…ave significantly improved treatment outcomes for patients with non-Hodgkin lymphoma. However, patients with aggressive disease experience high refr…